ALEXANDRIA, Va., May 19 -- United States Patent no. 12,630,617, issued on May 19, was assigned to Ablynx N.V. (Ghent-Zwijnaarde, Belgium) and Sanofi (Paris).
"Serum albumin binders" was invented by Stephanie Staelens (Wevelgem, Belgium), Soren Steffensen (Etterbeek, Belgium), Erika Morizzo (Cambridge, Great Britain) and An Cerdobbel (Nevele, Belgium).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to amino acid sequences that can bind to serum albumin. In particular, the present invention relates to immunoglobulin single variable domains, and in particular heavy-chain immunoglobulin single variable domains, that can bind to serum albumin. The invention also relates to proteins, po...